Advisor/Director Health Technology Assessment

We’re looking for people who are determined to make life better for people around the world.

The demand for high quality health economic and outcomes research (HEOR) and real-world evidence (RWE) to support drug development, health technology assessment/access decisions, product differentiation, and clinical decision making continues to increase. The purpose of the Lilly Value, Evidence, and Outcomes (VEO) team is to accelerate equitable patient access and transform healthcare delivery through the execution and communication of bold, high impact science. We are looking for talented, energetic, creative, diverse, influential, and collaborative team members to join the VEO function and Team Lilly.

TheVEO-International HTAscientist will provide strategic insight/leadership into the HTA needs for Lilly’sdiabetes & obesity portfolio. Thescientistwill use theirknowledge of health outcomes disciplines, therapeutic area knowledge ofdiabetes, understanding of drug development and commercialization, and geographic market knowledge in the role. Project ownership and executionisrequired. The scientistmay have duties ranging from developing and articulating product value propositions, health outcomes research strategy, evaluation of clinical, economic and /or patient reported outcomes methodologies, real world evidence generationand differentiation strategies using HEOR research.

Primary Responsibilities:

Strategy 

Drives sustained integration of HTA from early clinical development through commercialization depending on focus of role.

Develops and overseesHTA strategy for compounds in the Lilly portfolio in the relevant therapeutic area(s).

Serves as a strategic partner on lead/core teams throughout development and/or commercialization

Formulates and drives HTA deliverables, for priority products and geographies. 

Project Development and Execution

Develops bold high impact science for products across the lifecycle, to influence and support reimbursement and access needs for Lilly products in support of improving patient outcomes.

Applies technical expertise appropriate for the role (e.g., with depth in systematic review and network meta-analysis, cost-effectiveness analysis and other value assessments) within a therapeutic area.

Applies disease state knowledge and research methods to generate HTA deliverables for registration, pricing, reimbursement, accessand other external stakeholders such as health care practitioners. 

Organizational Leadership and Influence

Links technical expertise with business acumenand establishes and maintains strategic relationships with key internal and external decision makers.

Effectively leads HEOR evidence planning and implementation in collaboration with cross-functional teams across the development and commercialization lifecycle teams. 

Effectively integrates with and influences key business partners and external stakeholders to achieve goals and outcomes

Information Dissemination 

Effectively communicates HEOR evidence to internal business partners, the scientific community, and customers.

Drives dissemination strategies and leads research communication efforts includingabstracts, posters, podium presentations, promotional materials,and manuscripts.

Plan for, align, and drive application of results/ deliverables to increase the impact of HEOR evidence.

Environmental Awareness 

Maintains awareness of significant developments in disease states in the Lilly portfolio and HEORfield including current access and reimbursement policies, methodologies and applications and other issues as appropriate for the position.

Anticipates and evaluates future market needs and trends for HEOR information within pertinent therapeutic area and geography of interest.

Monitors and influences internal and external environmental factors that shape and impact generation and use of HEOR evidence.

Project Management 

Ensures HTAprojectsmeet timelines, budget, quality, and scope by coordinating research efforts with cross-functionalLilly business partners and external collaboratorsas appropriate.

Minimum Qualification Requirements:

Doctorate (PhD, MD)OR PharmD/MS degree withsignificant experience in creating, executing, and delivering outcomesstrategies/projects.

Proven track record in leading HEORevidence supporting pricing, reimbursement and access activities for successfully launched products.

Substantial experience in designing innovative and/or applying advanced methods for HEOR evidence.

Strong comprehension and communication skills including the ability to translate and disseminate complex scientific information in a clear and concise manner

Excellent written and verbal communication skills 

Demonstrated ability to influence and collaborate within and across teams

Additional Preferences/Information:

Understanding of health care systems in at least one ofEuropeand/or Asia

Understanding of and experience with health care deliverymodels and clinical research

Technical and analytic capabilities in the followingareas:health outcomes research, health economics, patient focused outcomes, burden of disease, epidemiology, statistics, health care policy

Demonstrated ability to drive research agendas to completion and dissemination

Abilityto think and act globally with a customer focus and a solution orientation

Creative thinking and ability to lead the generation of innovative approaches to real world evidence

Able to work within the demands of dynamic environment.

Additional Information:

Location is flexible in desired geography (Europe)

Domestic and international travel may be necessary.

Lilly does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status.

#WeAreLilly